Used primarily as an intermediate in the synthesis of pharmaceutical compounds, especially in the development of immune response modifiers. It serves as a key building block in the production of imidazoquinoline-based Toll-like receptor (TLR) agonists, which are important in immunotherapy and vaccine adjuvant research. Its structure supports the activation of TLR7 and TLR8 pathways, making it valuable in the design of antiviral and anticancer agents. Also utilized in research settings to develop novel small-molecule immune stimulants with potential application in treating infectious diseases and certain types of cancer.